A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly’s and Novo’s GLP-1 Duopoly
You probably already know that pharmaceutical powerhouses Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) dominate the anti-obesity drug…
You probably already know that pharmaceutical powerhouses Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) dominate the anti-obesity drug…
India’s aviation industry is poised for a reckoning after crises at its two dominant carriers exposed cracks in the booming…
Nic Carter believes that, given the new opportunities and realities in the stablecoin industry, the market is set to expand…